Kewaunee Scientific Co. (NASDAQ:KEQU) Short Interest Down 24.0% in February

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 46,500 shares, a decline of 24.0% from the February 13th total of 61,200 shares. Approximately 2.2% of the shares of the company are short sold. Based on an average daily volume of 27,200 shares, the short-interest ratio is currently 1.7 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.

Kewaunee Scientific Price Performance

Shares of KEQU stock traded up $0.18 during trading hours on Thursday, hitting $49.49. 12,243 shares of the company's stock were exchanged, compared to its average volume of 22,305. The stock's 50-day moving average is $57.92 and its 200-day moving average is $47.78. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The stock has a market cap of $142.14 million, a price-to-earnings ratio of 7.84 and a beta of 0.71. Kewaunee Scientific has a 52 week low of $30.82 and a 52 week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The company had revenue of $67.17 million for the quarter.

Remove Ads

Insider Activity

In other Kewaunee Scientific news, VP Douglas J. Batdorff sold 3,470 shares of the company's stock in a transaction on Monday, December 30th. The stock was sold at an average price of $65.50, for a total value of $227,285.00. Following the sale, the vice president now directly owns 5,000 shares in the company, valued at $327,500. This represents a 40.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Thomas David Hull III sold 2,000 shares of the company's stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $63.01, for a total value of $126,020.00. Following the completion of the sale, the chief executive officer now owns 42,497 shares in the company, valued at $2,677,735.97. This trade represents a 4.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,144 shares of company stock worth $629,216. Company insiders own 14.20% of the company's stock.

Hedge Funds Weigh In On Kewaunee Scientific

Several large investors have recently made changes to their positions in KEQU. Bank of America Corp DE lifted its stake in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after acquiring an additional 443 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after acquiring an additional 900 shares during the period. IFP Advisors Inc acquired a new position in Kewaunee Scientific in the fourth quarter valued at about $36,000. Morgan Dempsey Capital Management LLC acquired a new position in Kewaunee Scientific in the fourth quarter valued at about $106,000. Finally, Barclays PLC acquired a new position in Kewaunee Scientific in the third quarter valued at about $121,000. Institutional investors and hedge funds own 32.69% of the company's stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.